Clinical TrialsSearch results
Number of results: 973
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A mass balance study of [14C] TAS-303 in healthy adult male subjects
- Healthy adult male volunteer
- Jinhong Huang
- 2022-10-07
Completed
- A Mass Balance Study of [14C] TAS5315 in Healthy Adult Subjects
- healthy adult males
- Ali Nasermoaddeli
- 2023-10-12
Completed
- A Mass Balance Study of [14C]DS-1001b
- Healthy adult male
- Inoguchi Akihiro
- 2024-07-14
Completed
- A mass-balance study of [14C]KDT-3594 in healthy adult male
- Healthy condition
- Shimizu Yoshitaka
- 2022-10-16
Other
- A multi center, phase 2 study to Evaluate safety and efficacy of total Neoadjuvant treatment of long courSE radiotherapy followed by cheMotherapy, capecitaBine combined with oxaliplatin (CAPOX) for Locally advanced rEctal cancer(ENSEMBLE-2)
- Rectal cancer
- KAGAWA Yoshinori
- 2022-03-30
Other
- A multi institutional phase II study of oral fludarabine and rituximab (F-R therapy) for patients with relapsed or refractory mantle cell lymphoma.
- Mantle cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2008-10-11
Other
- A multi institutional phase II trial of peripheral blood stem cell transplantation for adult T cell leukemia/lymphoma following reduced intensity conditioning regimen.
- Adult T cell leukemia/lymphoma
- Grant for anticancer project from Ministry of Health, Welfare, and Labor of Japan
- 2006-05-01
Recruiting
- A multi-centered study of feasibility in endoscopic closure using novel simple flexible device for mucosal defect after gastric endoscopic submucosal dissection
- Gastric Neoplasms
- Takizawa Kohei
- 2022-11-02
Other
- A multicenter phase I/II study of irinotecan (CPT-11) and S-1 combination chemotherapy for metastatic colorectal cancer (CRC)
- advanced/recurrent colorectal cancer
- CPT-11/TS-1 study group
- 2009-01-06
Other
- A multicenter phase II open-label study in untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma evaluating efficacy and safety of maintenance therapy with IDEC-C2B8.
- Untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma.
- Zenyaku Kogyo Co., Ltd.
- 2008-12-26